Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both

Renato D Lopes1, Karen S Pieper2, Susanna R Stevens2

  • 1Duke Clinical Research Institute, Duke University Medical Center, Durham, NC renato.lopes@duke.edu.

Insights

Updated patient data significantly improves mortality prediction after myocardial infarction (MI). Dynamic risk assessment, incorporating evolving clinical information, offers better prognostic accuracy than static baseline models for patients with heart failure (HF) or left ventricular dysfunction post-MI.

Area of Science:

  • Cardiology
  • Clinical Risk Assessment
  • Outcomes Research

Background:

  • Traditional myocardial infarction (MI) risk assessments are static, failing to capture dynamic changes in patient status and care.
  • There is a need for dynamic risk models that account for evolving clinical events and processes post-MI.

Purpose of the Study:

  • To identify predictors of mortality, cardiovascular death or nonfatal MI, and cardiovascular death or nonfatal heart failure (HF) over time in post-MI patients.
  • To develop and validate dynamic risk models for predicting adverse cardiovascular outcomes in post-MI patients.

Main Methods:

  • Utilized data from the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
  • Developed multivariable Cox proportional hazards models to assess risk over specific time intervals (e.g., hospital arrival to discharge, 30 days to 6 months, 6 months to 3 years).
  • Compared the predictive accuracy of models using updated patient information versus baseline data.

Main Results:

  • Age, baseline heart rate, and creatinine clearance were strong predictors of overall mortality in the baseline model.
  • Updated patient information significantly improved the prediction of mortality, cardiovascular death/nonfatal MI, and cardiovascular death/nonfatal HF across all follow-up periods.
  • Integrated Discrimination Improvement (IDI) and Net Reclassification Improvement (NRI) indices demonstrated significant enhancements with updated models.

Conclusions:

  • Patient information assessed closer to the outcome event is more valuable for predicting mortality than data from the initial hospitalization.
  • Employing updated patient information in risk models substantially improves prognostic accuracy compared to using only baseline data.
  • Dynamic risk stratification offers a more precise approach to managing patients post-MI, particularly those with heart failure or left ventricular systolic dysfunction.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
539
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
478
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
636
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.2K